logo

MEDICIS PH(NYSE:MRX)
Medicis is an independent pharmaceutical company focusing exclusively on the treatment of dermatological conditions. Medicis offers prescription, over-the-counter and physician-dispensed dermatology products, emphasizing the clinical effectiveness, quality, affordability and cosmetic elegance of its products. Medicis has achieved a leading position in branded products for the treatment of acne, acne-related conditions, psoriatic conditions and pruritic conditions, while also offering the leading over-the-counter topical analgesic and fade cream product in the U.S.
# Employees: 578
Address: 7720 N. Dobson Road,Scottsdale,,USA
Phone: 602 808-8800
Fax: 602-808-0822
Website: www.medicis.com
Email: investor_relations@medicis.com
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Jonah Shacknai (Chmn.; C.E.O.; Dir.)
Richard D. Peterson (Exec. V.P.; C.F.O.; Treas.)
Arthur G. Altschul Jr. (Dir.)
Spencer Davidson (Dir.)
Stuart Diamond (Dir.,)
Dividend
Ex-Dividend Date: 9/29/2009
Annual Dividend: $0.16
Current Dividend Yield: $0.68
Dividend Paid (3 months): $0.04
Indicated Dividend: $0.13
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/24/2010
Mean EPS (Next Qtr): $0.60
Mean EPS (Year): $1.58
Mean Estimate(Long Term): $14.05
P/E Ratio(Based on EPS estimate): 14.960
Number of Estimates: 18
Shares Performance
Period MRX Compare to S&P
YTD 69.86 % 40.56 %
4 Weeks 11.53 % 5.88 %
12 Weeks 26.05 % 17.38 %
Shares Information
Analyst Coverage: Y
Avg Volume: 790330
Shares Outstanding: 59M
Market Cap: $1.40B
52 Week High: $24.38
52 Week Low: $9.65
P/E Ratio: 19.190
PEG Ratio: 1.060
Split: On 1/26/2004 MRX split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -15.38 %
EPS Growth in Last Year: 22.22 %
Sales Growth in Last Quarter: 7.48 %
Sales Growth in Last Quarter: 31.52 %
Financials
Qtr Book Value: $2.16
Cash Flow/Share: $10.56
Change in Payout Ratio: 0.020
Price/Sales: 2.650
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia